2025商业健康险医药行业与医疗机构协同创新案例研究报告-RDPAC
清华大学五道口金融学院中国保险与养老金融研究中心 中国外商投资企业协会药品研制和开发工作委员会(RDPAC) 摘 要····························································································· 1
清华大学五道口金融学院中国保险与养老金融研究中心 中国外商投资企业协会药品研制和开发工作委员会(RDPAC) 摘 要····························································································· 1
清华大学五道口金融学院中国保险与养老金融研究中心 中国外商投资企业协会药品研制和开发工作委员会(RDPAC) 摘 要····························································································· 1
清华大学五道口金融学院中国保险与养老金融研究中心 中国外商投资企业协会药品研制和开发工作委员会(RDPAC) 摘 要····························································································· 1核心数据:二、三方协同创新案例的主要探索方向················································· 5;(七)从“医保补充型”向“医保替代型”——柏盛健康推动健康险市场转型························ 8;(八)海外市场可参考经验· ······························································ 8。
本报告由清华大学五道口金融学院中国保险与养老金融研究中心发布,发布于 2025 年。
覆盖 2025 年,全文约 21。
本报告免费查阅,登录资料宝后即可在线获取完整内容。
适合战略规划、行业研究员等读者参考。
重点分析了创新药、药品等议题。